![](/img/cover-not-exists.png)
Clinical Outcomes of Patients Receiving Fluoroquinolones to Treat Bacteremia Caused by Enterobacteriaceae Isolates Considered Intermediate or Resistant to These Agents According to the Recently Revised Susceptibility Testing Standards by the Clinical and Laboratory Standards Institute (CLSI)
Tulloch, Luis, Martin, Elise, Uslan, Daniel Z, Humphries, RomneyVolume:
4
Journal:
Open Forum Infectious Diseases
DOI:
10.1093/ofid/ofx163.1447
Date:
October, 2017
File:
PDF, 187 KB
2017